Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?

Jan 02 2019

• By Derrick Gingery and David Filmore

Close-up of little On/Off switch with soft blurred background - Image

Related Content

Shutdown Week Two: Could Sponsors Find A More Focused FDA?

Oct 14 2013

The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

Apr 08 2018

ANDA Complete Responses Spike In FY 2018, But Why?

Jan 20 2018

Shutdown Winds Down: Short 'Lapse Period' Likely Means Few Disruptions At US FDA

Jan 23 2018

FDA Recruitment Hurt By Sequester, Shutdown – Hamburg

Apr 14 2014

US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal

Jan 22 2018

Government Shutdown Causes Backlog Of 100 Device Submissions, With More Expected

Oct 24 2013

Is Bloom Gone From Rosy ANDA Approvals Figures?

Nov 12 2018

CDER Recruitment Wins Begin Outnumbering Losses

Nov 27 2018

Global Device Approvals, Weekly Snapshot: FoundationOne CDx In Japan

Dec 31 2018

Additional Topics

United States FDA Regulation Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window